+91-98 455 710 46 | info@nckpharma.com
Tag

Allena’s oxalate decarboxylase to treat paediatric hyperoxaluria gets US FDA orphan drug status

Allena’s oxalate decarboxylase to treat paediatric hyperoxaluria gets US FDA orphan drug status

Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on developing and commercialising innovative, non-systemic, oral protein therapeutics to treat metabolic and orphan...
Read More

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests 

etc.